We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Fitch Brew Co has developed a new approach to coffee in the form of cold brew coffee. The brand has been designed to target the alcohol industry and work behind the bar with a flavour specifically developed to compliment alcoholic drinks. 
days to go: Expired investment: £148,280
VitaLife founded Love Health Hate Waste out of their frustration for throwing away unsold/ expired stock. Love Health Hate Waste aim to reduce food waste and make healthy food and drink accessible to everyone. 
days to go: Expired investment: £6,910
Comesto is a peer to peer web and app based service that enables professional food buyers to purchase directly from suppliers.  They are a membership funded trading platform.  The platform gives their members access to the whole market eliminating single brochures.  Comesto offers industry buyers a complete purchasing, invoicing and scheduling management service and for suppliers their aim is to provide a simple cost effective way to increase sales.  
days to go: Expired investment: £34,970
A themed cocktail bar owner, craft beer brewer and gin brand creator that serves thousands of customers on a weekly basis. Liquid Art Group currently have 3 locations within affluent areas of Manchester and are now raising funds to open 12 more sites across the UK over the next 3 years. The company has become highly profitable and are ready to duplicate their proven business model after successfully running in a niche area of their market. More sites will result in reduced costs due to purchasing bulk goods from existing suppliers in greater quantities. This means that profit margins will increase, whilst more locations will provide additional streams of revenue. Liquid Art Group is also planning to develop and distribute their range of gin by creating new flavours and offerings.
days to go: Expired investment: £129,080
NGX is the world’s first genetically personalised nutrition shake designed to bring nutrition to everyday athletes. The company has ongoing discussions to form partners with U.A.E and U.S to expand. NGX's nutritionist approved formula is a less than average vegan-friendly, environmentally responsible, allergen-free, naturally sourced, and macro trends within the millennial and Z generations. With the proceeds, the company aims to create a range of products from personalised meal plans, and protein bars to enhance its position as the go-to personalised nutrition brand.

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £207,860
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph